Gastrointestinal Cancers Clinical Trials

12 recruitingLast updated: June 18, 2026

There are 12 actively recruiting gastrointestinal cancers clinical trials across 5 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Los Angeles, California, United States, Columbus, Ohio, United States, Dallas, Texas, United States. Updated daily from ClinicalTrials.gov.


Gastrointestinal Cancers Trials at a Glance

12 actively recruiting trials for gastrointestinal cancers are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Los Angeles, Columbus, and Dallas. Lead sponsors running gastrointestinal cancers studies include Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), Ankara Oncology Research and Training Hospital, and Affiliated Hospital of Qinghai University.

Browse gastrointestinal cancers trials by phase

Treatments under study

About Gastrointestinal Cancers Clinical Trials

Looking for clinical trials for Gastrointestinal Cancers? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastrointestinal Cancers trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastrointestinal Cancers clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Personalized Health Self-Management Training for Colorectal Cancer Survivors

Colorectal, CancerGastrointestinal CancersHealth Behavior+2 more
University of Southern California120 enrolled2 locationsNCT05984589
Recruiting
Phase 2

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

Gynecologic CancersEsophageal CancerGastrointestinal Cancers
John Waters50 enrolled1 locationNCT07039526
Recruiting
Phase 2

Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers

Gastrointestinal Cancers
Genmab160 enrolled2 locationsNCT07539311
Recruiting
Not Applicable

Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

Risk of Breast CancerRisk of Gynaecological CancerRisk of Colorectal Cancer+14 more
Gustave Roussy, Cancer Campus, Grand Paris5,909 enrolled1 locationNCT06907095
Recruiting
Not Applicable

Feasibility Study of CBCT for IGRT in Cancer Patients

Breast CancerLiver CancerHead and Neck Cancers+3 more
Varian, a Siemens Healthineers Company50 enrolled4 locationsNCT06681233
Recruiting
Not Applicable

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Liver CancerBiliary Tract CancerColon Cancer+76 more
Cedars-Sinai Medical Center360 enrolled1 locationNCT04907643
Recruiting

Predictive Value of Preoperative Rectus and Diaphragm Muscle Thickness for Postoperative Complications in Gastrointestinal Cancer Surgery

Gastrointestinal CancersComplication
Ankara Oncology Research and Training Hospital300 enrolled1 locationNCT07098871
Recruiting
Not Applicable

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

Gynecologic CancersColorectal, CancerBiliary Tract Cancer+8 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)48 enrolled1 locationNCT06731998
Recruiting
Not Applicable

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

CancerCancer SurvivorsNeuroendocrine Tumors+2 more
Barbara Ann Karmanos Cancer Institute120 enrolled1 locationNCT06908629
Recruiting
Phase 3

Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers

Gastrointestinal Cancers
Sun Yat-sen University136 enrolled1 locationNCT06966232
Recruiting
Not Applicable

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome

Breast CancerElectroacupunctureCapecitabine+3 more
Affiliated Hospital of Qinghai University220 enrolled1 locationNCT06602167
Recruiting

PRecision Oncology CUhk pRogrammE (PRO-CURE)

Gastrointestinal Cancers
Brigette Ma200 enrolled1 locationNCT04724070